Recent And Upcoming FDA Advisory Committee Meetings
Executive Summary
Recent and upcoming FDA advisory committee meetings and a summary of topics covered.
|
Topic |
Advisory Committee |
Date |
|
Ferring Pharmaceuticals’ Nocdurna (desmopressin) orally disintegrating sublingual tablets for treatment of nocturia due to nocturnal polyuria in adults who awaken two or more times each night to void |
Endocrinologic and Metabolic Drugs |
Jan. 12 |
|
Astellas’ isavuconazonium sulfate capsules and injection for treatment of invasive aspergillosis and mucormycosis |
Anti-Infective Drugs |
Jan. 22 |
|
Influenza virus vaccine strain selection for the 2015-2016 flu season |
Vaccines and Related Biological Products |
March 4 |
|
Progress report or a final draft report from the Commissioner's Fellowship Program Evaluation subcommittee; progress report from the Science Moving Forward subcommittee; FDA's public access policy; approaches to regulatory science training coordination; activities regarding the re-introduction of bovine heparin; overview of science-related activities from one of the centers; presentation by a recipient of the Fiscal Year 2014 Scientific Achievement Awards |
Science Board |
March 4 |